ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer.
about
The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancersLymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumoursMolecular pathology of ataxia telangiectasiaGenes other than BRCA1 and BRCA2 involved in breast cancer susceptibilityMore breast cancer genes?The p53 pathway in breast cancerThe intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in AustraliaNot All Next Generation Sequencing Diagnostics are Created Equal: Understanding the Nuances of Solid Tumor Assay Design for Somatic Mutation DetectionMolecular and Functional Characterization of a Cohort of Spanish Patients with Ataxia-TelangiectasiaNovel mutations and defective protein kinase C activation of T-lymphocytes in ataxia telangiectasiaLoss of p53 Ser18 and Atm results in embryonic lethality without cooperation in tumorigenesisRadiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk.Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study.Cancer risk and the ATM gene: a continuing debate.Computational refinement of functional single nucleotide polymorphisms associated with ATM geneMolecular differences between small and large cells in patients with chronic lymphocytic leukemia.Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.Do novo del(9)(p13) in a childhood T-cell prolymphocytic leukemia as sole abnormalityAtaxia-telangiectasia, cancer and the pathobiology of the ATM gene.A new ataxia-telangiectasia mutation in an 11-year-old femaleEvaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage ConsortiumMissense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.A-TWinnipeg: Pathogenesis of rare ATM missense mutation c.6200C>A with decreased protein expression and downstream signaling, early-onset dystonia, cancer, and life-threatening radiotoxicityImmunodeficiency associated with DNA repair defects.Low levels of ATM in breast cancer patients with clinical radiosensitivity.New mutations in the ATM gene and clinical data of 25 AT patients.The association between ATM IVS 22-77 T>C and cancer risk: a meta-analysis.Haplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium.Multifunctional role of ATM/Tel1 kinase in genome stability: from the DNA damage response to telomere maintenanceTherapy related leukemias: susceptibility, prevention and treatment.ATM gene and lymphoid malignancies.Ataxia telangiectasia gene mutations in leukaemia and lymphoma.Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences.Cancer risks and mortality in heterozygous ATM mutation carriers.ATM and breast cancer susceptibility.ATM mutations in sporadic lymphoid tumours.Mutation at intronic repeats of the ataxia-telangiectasia mutated (ATM) gene and ATM protein loss in primary gastric cancer with microsatellite instabilityMantle cell lymphoma is characterized by inactivation of the ATM gene.
P2860
Q21260410-F7BD0F43-F893-495A-959F-6CDCBE7A758EQ24597674-A5761948-1CB2-4772-8824-9D38B2C2770FQ24672363-C8A04C74-F737-423C-8CEA-8F077839452FQ24679438-E3D5112C-FBB5-40C3-985D-48E31A0C1143Q24801368-6CE7740E-4846-4F14-B81A-107A3A96C872Q24802349-F10160B9-4CFF-4655-8B96-F6A1767363F1Q24806016-CAAC4277-6FE2-457A-9127-C159D59270DFQ26801745-49F51E30-7412-44CA-999B-C292EC8EF7B2Q28117038-1122D7D9-EB59-43A1-8577-69094D84E3A2Q28362325-DFCA0724-30BF-4815-8812-D0E4EC1B05F6Q28477245-A434EDCE-1670-4CA6-8079-C5E4B562A036Q30432746-9AD7C1EF-C049-4D0C-A836-A179EAF831E5Q30437897-AA7E1A00-2FB4-44E6-919A-FE683A6F05C8Q30438940-A47C1702-DCD3-4025-8285-1D509163E302Q30478981-A16169EC-ADB0-41F4-B007-7A4BAAE5DF00Q30871076-940A8781-49AC-4A07-BCC5-A97568C860DBQ31056468-1FC0D3D9-1454-4AD6-ADD8-E02F3CDC9342Q31155471-55ED70D9-4C34-4DDC-901E-5663F9045751Q33258847-27A11334-D77F-4FE4-9B35-97CEEE19364EQ33422687-06334A85-D1DE-4BF6-842A-C9F8B674CBF2Q33697357-32E989F5-DE64-465C-AE65-8BE91195DFF2Q33841531-90CE3C1C-D078-478F-9915-2DD998C0F19DQ33894527-A87E8D89-942E-413D-8BF0-7144E54201B9Q33894683-53479AC7-A1CF-4A34-AE93-A4E80037EB64Q33960818-7CA9DCF4-019D-4753-A1CA-140958840B49Q33962066-1B62BBE1-681F-4859-92B0-EDE88BBEFC54Q34036288-69B62F05-23E3-4E20-81DC-A81D9F07A29CQ34037422-01D3FF13-6C1C-47F1-ABE9-5FDE10965C2CQ34140207-5FC21793-79FC-4216-AAD4-659C46613674Q34144298-72AE4FB2-630B-4EA1-9805-FFFD32A11FF3Q34176919-C307B3B5-580B-4783-B947-1E415005CDE0Q34265193-B6F198E9-F92B-4315-949B-FE3680A696B1Q34277980-7175F7FE-0995-4A30-BD1B-FEE9807559FCQ34295109-821574B8-EE7B-4306-A8BD-5365EE86B690Q34389747-17D09C5F-4C8C-4561-AFC9-1323AFC7B51AQ34422846-5C477723-6BEC-47E0-90F0-6DD73C9416DBQ34568565-023A87C3-EE1F-4AAF-B1C0-057AB363CA1AQ34980360-CAA6FE5D-6601-47FB-85E2-D37CF8B586A5Q35064299-31A54E96-890B-4880-ADD2-67C764382688Q35081325-C45DB1AD-F580-4D9F-8BBA-F5DDBD1096B1
P2860
ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer.
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
ATM mutations and phenotypes i ...... , lymphoma, and breast cancer.
@ast
ATM mutations and phenotypes i ...... , lymphoma, and breast cancer.
@en
ATM mutations and phenotypes i ...... , lymphoma, and breast cancer.
@nl
type
label
ATM mutations and phenotypes i ...... , lymphoma, and breast cancer.
@ast
ATM mutations and phenotypes i ...... , lymphoma, and breast cancer.
@en
ATM mutations and phenotypes i ...... , lymphoma, and breast cancer.
@nl
prefLabel
ATM mutations and phenotypes i ...... , lymphoma, and breast cancer.
@ast
ATM mutations and phenotypes i ...... , lymphoma, and breast cancer.
@en
ATM mutations and phenotypes i ...... , lymphoma, and breast cancer.
@nl
P2093
P2860
P356
P1476
ATM mutations and phenotypes i ...... , lymphoma, and breast cancer.
@en
P2093
A M Taylor
A R Bradwell
A Sutcliffe
G G Lennox
G M McGuire
P Robinson
P2860
P304
P356
10.1086/301706
P407
P577
1998-02-01T00:00:00Z